Estrogenic Activity: none
Progestational Activity: none
Primary active ingredient (17a-methyl-etioallocholan-17b-ol-3-hydroxyimine) was first described by Z. Cekan and B. Pelc, Effects of 1-alkyl substitution on the biological action in a series of androstanes. Steroids 8,209 (1966).
Never commercially produced A COMPLETELY NOVEL MOLECULE.
The One can inhibit the action of estrogens by acting as a competitive antagonist and/or decreasing the mRNA-induced transcription of estrogenic effects post-binding.
The One can also act like an aromatase inhibitor, disallowing the conversion of androgens to estrogen.
The One activates GLUT-4 receptors in skeletal muscle, and also increases glycogen uptake. The One is 17-alpha alkylated greater oral bioavailability.
The One can significantly lower SHBG levels, allowing for more active product to reach skeletal muscle.
Effects Related to Physique Enhancement:
Rapid lean body mass gains - typical users report 0.75 lb./day gains for first 2-3 weeks
Overall hardening effect to physique
Dramatically neural function (coordination) as DHT is the predominant androgen in neural function
Lipolytic effect (increases fat metabolism)
Effective dose: 67.5 - 90 mg/day (3-4 capsules) ; DO NOT EXCEED 90 MG/DAY
Can be taken with or without food; preferably in the AM
Oral Administration Only
4-5 week administration period; do not exceed 5 weeks duration[/QUOTE]